AC-262 536 is a non-steroidal selective androgen receptor modulator (SARM). Initial research on this SARM started in 2007 with animal studies, and there have been no human trials or studies done on it since. AC-262,536 binds directly with the androgen receptor reducing the risk of increased prostate cancer risk, shrinking testicles and effecting sexual tissue. But still helps develop strong bones and bigger muscles.
AC-262536 has shown it could be more potent than testosterone in animal models in binding receptors and suppressing the luteinization hormone (LH). Research from AC-262536 indicated that testosterone could also enhance muscle development. AC-262 536 may have prostate cancer benefits because they can have a significant impact on human cancer cell prostate cancer effects of dihydrotestosterone (DHT) (in vitro).
AC-262 536 Specifications
Molar Mass: 278.355 g·mol−1
Like AC-262 536? Check out our other support supplements HERE
Disclaimer: All products listed on this website and provided through Pharma Lab Global are intended for medical research purposes only. Pharma Lab Global does not encourage or promote the use of any of these products in a personal capacity (i.e. human consumption), nor are the products intended to be used as a drug, stimulant or for use in any food products.